We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Bioengineering of dental stem cells in a PEGylated fibrin gel

    Kerstin M Galler

    Department of Restorative Dentistry & Periodontology, University of Regensburg, Regensburg, Germany

    ,
    Adriana C Cavender

    Department of Biomedical Sciences, Baylor College of Dentistry, Texas A&M, Dallas, TX, USA

    ,
    Umut Koeklue

    Department of Restorative Dentistry & Periodontology, University of Regensburg, Regensburg, Germany

    Department of Biomedical Sciences, Baylor College of Dentistry, Texas A&M, Dallas, TX, USA

    ,
    Laura J Suggs

    Department of Biomedical Engineering, University of Texas at Austin, Austin, TX, USA

    ,
    Gottfried Schmalz

    Department of Restorative Dentistry & Periodontology, University of Regensburg, Regensburg, Germany

    &
    Published Online:https://doi.org/10.2217/rme.11.3

    Aim: Postnatal stem cells can generate tooth-specific structures after transplantation in vivo, which makes them a valuable tool for dental tissue engineering. Scaffold materials that are compatible with dental stem cells, injectable and tunable for targeted regeneration are needed. A candidate material is fibrin, a biopolymer critical to hemostasis and wound healing. Rapid degradation of fibrin can be decelerated by modification with polyethylene glycol (PEG), thus creating a hybrid material for cell delivery. The aim of this study was to evaluate the suitability of PEGylated fibrin as a scaffold for dental stem cells. Methods: A PEGylated fibrin hydrogel was combined with stem cells derived from dental pulp or periodontal ligament. Cell proliferation was assessed over a 4-week period, and alkaline phosphatase activity and expression levels of mineralization-associated genes after osteogenic induction were analyzed. Cell morphology, matrix degradation, collagen production and mineral deposition were evaluated by histology. Constructs of PEGylated fibrin with dental pulp stem cells in dentin disks were transplanted in immunocompromised mice for 5 weeks and examined for new tissue formation. Results: All cell types proliferated in PEGylated fibrin. After osteogenic induction, alkaline phosphatase activity was higher and osteoblast-specific genes were upregulated. Dentin-specific markers increased in pulp-derived stem cells. Histologic analysis revealed degradation of fibrin, production of a collagenous matrix and mineral deposition. In vivo transplantation rendered a vascularized soft connective tissue similar to dental pulp. Conclusion: Fibrin allows for the growth and differentiation of dental stem cells, can be inserted into small defects and thus appears to be a promising biomaterial for tissue regeneration in the oral cavity.

    Bibliography

    • Petersen PE: World Health Organization global policy for improvement of oral health – World Health Assembly 2007. Int. Dent. J58(3),115–121 (2008).
    • Miura M, Gronthos S, Zhao M et al.: SHED: Stem cells from human exfoliated deciduous teeth. Proc. Natl Acad. Sci. USA100(10),5808–5812 (2003).
    • Gronthos S, Mankani M, Brahim J, Robey PG, Shi S: Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl Acad. Sci. USA97(25),13625–13630 (2000).
    • Seo BM, Miura M, Gronthos S et al.: Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet364(3429),149–155 (2004).
    • Huang GT, Gronthos S, Shi S: Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J. Dent. Res.88(9),792–806 (2009).
    • Bohl KS, Shon J, Rutherford B, Mooney DJ: Role of synthetic extracellular matrix in development of engineered dental pulp. J. Biomater. Sci. Polym. Ed.9(7),749–764 (1998).
    • Prescott RS, Alsanea R, Fayad MI et al.: In vivo generation of dental pulp-like tissue by using dental pulp stem cells, a collagen scaffold, and dentin matrix protein 1 after subcutaneous transplantation in mice. J. Endod.34(4),421–426 (2008).
    • Cordeiro MM, Dong Z, Kaneko T et al.: Dental pulp tissue engineering with stem cells from exfoliated deciduous teeth. J. Endod.34(8),962–969 (2008).
    • Sakai VT, Zhang Z, Dong Z et al.: SHED differentiate into functional odontoblasts and endothelium. J. Dent. Res.89(8),791–796 (2010).
    • 10  Huang GT, Yamaza T, Shea LD et al.: Stem/progenitor cell-mediated de novo regeneration of dental pulp with newly deposited continuous layer of dentin in an in vivo model. Tissue Eng. Part A16(2),605–615 (2010).
    • 11  Sonoyama W, Liu Y, Fang D et al.: Mesenchymal stem cell-mediated functional tooth regeneration in swine. PLoS ONE1,e79 (2006).
    • 12  Huang GT, Sonoyama W, Chen J, Park S: In vitro characterization of human dental pulp cells: various isolation methods and culturing environments. Cell Tissue Res.324(2),225–236 (2006).
    • 13  Ahmed TA, Dare EV, Hincke M: Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng. Part B Rev.14(2),199–215 (2008).
    • 14  Zhang G, Wang X, Wang Z, Zhang J, Suggs LJ: A PEGylated fibrin patch for mesenchymal stem cell delivery. Tissue Eng.12(1),9–19 (2006).
    • 15  Shibata Y, Fujita S, Takahashi H, Yamaguchi A, Koji T: Assessment of decalcifying protocols for detection of specific RNA by non-radioactive in situ hybridization in calcified tissues. Histochem. Cell Biol.113(3),153–159 (2000).
    • 16  Schmoekel HG, Weber FE, Schense JC, Grätz KW, Schawalder P, Hubbell JA: Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnol. Bioeng.89(3),253–262 (2005).
    • 17  Drinnan CT, Zhang G, Alexander MA, Pulido AS, Suggs LJ: Multimodal release of transforming growth factor-β1 and the BB isoform of platelet derived growth factor from PEGylated fibrin gels. J. Control. Release147(2),180–186 (2010).
    • 18  Briganti E, Spiller D, Mirtelli C: A composite fibrin-based scaffold for controlled delivery of bioactive pro-angiogenetic growth factors. J. Control. Release147(1),14–21 (2010).
    • 19  Jung Y, Chung YI, Kim SH et al.: In situ chondrogenic differentiation of human adipose tissue-derived stem cells in a TGF-β1 loaded fibrin-poly(lactide-caprolactone) nanoparticulate complex. Biomaterials30(27),4657–4664 (2009).
    • 20  Liu H, Collins SF, Suggs LJ: Three-dimensional culture for expansion and differentiation of mouse embryonic stem cells. Biomaterials27(36),6004–6014 (2006).
    • 21  Ranley DM, Garcia-Godoy F: Current and potential pulp therapies for primary and young permanet teeth. J. Dent.28(3),153–161 (2000).
    • 22  Pierdomenico L, Bonsi L, Calvitti M et al.: Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation80(6),836–842 (2006).
    • 23  Trubiani O, Tripodi D, Delle Fratte T, Caputi S, Di Primo R: Human dental pulp vasculogenesis evaluated by CD34 antigen expression and morphological arrangement. J. Dent. Res.82(9),742–747 (2003).
    • 24  Gandia C, Arminan A, Garcia-Verdugo JM: Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction. Stem Cells26(3),638–645 (2008).
    • 101  Primer3: WWW primer tool http://biotools.umassmed.edu/bioapps/primer3_www.cgi
    • 102  Microbiology and immunology online http://pathmicro.med.sc.edu/pcr/realtime-home.htm